ReoPro

In the US, ReoPro (abciximab systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat High Risk Percutaneous Transluminal Angioplasty.

US matches:

• ReoPro

Ingredient matches for ReoPro

Abciximab

Abciximab is reported as an ingredient of ReoPro in the following countries:

• Australia


• Austria


• Belgium


• Brazil


• Bulgaria


• Canada


• Chile


• Czech Republic


• Denmark


• Finland


• Germany


• Greece


• Hong Kong


• Iceland


• India


• Ireland


• Israel


• Italy


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Peru


• Poland


• Romania


• Russian Federation


• Serbia


• Singapore


• South Africa


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States

International Drug Name Search